Breaking News Instant updates and real-time market news.

LDOS

Leidos

$56.65

0.47 (0.84%)

, SPR

Spirit AeroSystems

$69.73

-0.01 (-0.01%)

10:49
08/10/17
08/10
10:49
08/10/17
10:49

Goldman says buy Leidos, sell Embraer as rising tensions boost defense stocks

In a research note regarding the aerospace and defense sector, Goldman Sachs analyst Noah Poponak upgraded Leidos (LDOS) to Buy on strong free cash and Spirit AeroSystems (SPR) to Neutral on better cash generation, while cutting the firm's ratings on Embraer (ERJ) and Esterline (ESL) to Sell. AEROSPACE, DEFENSE STOCKS DOING WELL: Goldman Sachs' Poponak pointed out in a research note to investors that the Aerospace and Defense sector has performed well this year despite market concerns on valuation in Defense and the point of the cycle in Aerospace. Additionally, the analyst noted that defense and aftermarket have been strong as end markets and he continues to favor them. BUY LEIDOS: Poponak upgraded Leidos to Buy, with a $68 price target, as he thinks the market is underestimating revenue, earnings and especially cash flow potential in 2018 and 2019. Large programs are set to accelerate in 2018, while more IS&GS merger synergies come through, and a reversal of working capital should drive outsized free cash versus investor expectations, the analyst contended, adding that Leidos is the least expensive Defense stock he covers. Poponak highlighted that the Defense budget growth should drive accelerating revenue in both 2018 and 2019. SPIRIT PERFORMING BETTER: Meanwhile, Goldman Sachs' Poponak also upgraded Spirit AeroSystems to Neutral from Sell and raised his price target on the shares to $68 from $54. While he acknowledged that he remains concerned with Aerospace OE medium-term, he noted that narrowbody demand has remained resilient and is 60% of the company's revenue. Further, the analyst pointed out that Spirit has performed better on margins and free cash than he had anticipated. SELL EMBRAER, ESTERLINE: Also this morning, Poponak double-downgraded Embraer to Sell from Buy, with a $18 price target, and cut Esterline's rating also to Sell from Neutral, with a $75 price target. While Embraer implemented its cost reduction plan, margin improvement did not follow, the analyst told investors, adding that he believes margins have new headwinds going forward. Poponak pointed out that the EJet skyline has substantial holes post 2017, and regional jet demand has been weak. Moreover, he noted that challenges remain in business jet and Brazil Defense. With weak volume and pricing ahead, and the cost reduction plan already implemented, EBIT and cash flow could disappoint, the analyst contended. Regarding Esterline, Poponak told investors that its margins have been trending lower since it first implemented its operational turnaround plan several quarters ago. The analyst noted he also sees growth headwinds in Aero and the non-A&D businesses. There are signs Esterline has been losing share or price, he contends, adding that initial 2018 guidance could be well below expectations. BAIRD UPS RAYTHEON TARGET: His peer at Baird also raised Raytheon's (RTN) price target to $212 from $170 this morning to reflect significant program wins both domestically and internationally for missile defense and missile systems that puts the company in position for favorable organic growth in 2018 and beyond. Analyst Peter Arment reiterated an Outperform rating on the shares. WHAT'S NOTABLE: Defense stocks rallied on Wednesday, a day after President Donald Trump warned that threats from North Korea "will be met with fire and fury." However, the rest of the market fell on concerns about increased geopolitical tensions in the area. Other publicly traded companies in the sector include Lockheed Martin (LMT), Northrop Grumman (NOC) and L3 Technologies (LLL). PRICE ACTION: In morning trading, shares of Leidos have gained almost 1% to $56.56, while Spirit's stock is fractionally down to $69.68. Embraer and Esterline are down about 4% and 2% to $20.65 and $85.70, respectively.

LDOS

Leidos

$56.65

0.47 (0.84%)

SPR

Spirit AeroSystems

$69.73

-0.01 (-0.01%)

ERJ

Embraer

$20.65

-0.75 (-3.50%)

ESL

Esterline

$85.85

-1.75 (-2.00%)

RTN

Raytheon

$180.50

1.2 (0.67%)

LMT

Lockheed Martin

$306.81

1.59 (0.52%)

NOC

Northrop Grumman

$273.05

-0.05 (-0.02%)

LLL

L3 Technologies

$183.65

1.92 (1.06%)

  • 23

    Aug

LDOS Leidos
$56.65

0.47 (0.84%)

08/10/17
GSCO
08/10/17
UPGRADE
Target $68
GSCO
Buy
Leidos upgraded to Buy from Neutral at Goldman Sachs
Goldman analyst Noah Poponak upgraded Leidos to Buy and increased its price target to $68 from $61 saying he expects large programs to accelerate in 2018, combined with IS&GS merger synergies, and a reversal in working capital that should drive free cash above investor expectations.
06/06/17
SBSH
06/06/17
NO CHANGE
Target $60
SBSH
Buy
Veterans Affairs decision may be good for Leidos, says Citi
Citi analyst Jonathan Raviv believes the Department of Veterans Affairs' announcement yesterday that it will adopt the same core for its Electronic Health Record system as used at the Department of Defense may be good news for Leidos (LDOS). Leidos is the lead integrator on the Department of Defense implementation, which uses Cerner's (CERN) Millennium product, Raviv tells investors in a research note. The analyst keeps a Buy rating on Leidos with a $60 price target.
03/16/17
VERT
03/16/17
INITIATION
VERT
Buy
Leidos initiated with a Buy at Vertical Research
Vertical Research analyst Krishna Sinha started Leidos with a Buy rating.
02/24/17
FBCO
02/24/17
NO CHANGE
Target $65
FBCO
Outperform
Leidos price target raised to $65 from $57 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Leidos to $65 from $57 as "strong performance" drove guidance boos and accelerated debt paydown. The analyst continues to see relative upside for Leidos from the additional levers enabled by the IS&GS acquisition, from cost synergies, deleveraging, and eventually from revenue synergies. He reiterates an Outperform rating on the shares.
SPR Spirit AeroSystems
$69.73

-0.01 (-0.01%)

08/10/17
GSCO
08/10/17
UPGRADE
Target $68
GSCO
Neutral
Spirit AeroSystems upgraded to Neutral from Sell at Goldman Sachs
Goldman analyst Noah Poponak upgraded Spirit AeroSystems to Neutral and increased its price target to $68 from $54 telling investors the company has performed better on margins and free cash flow than he anticipated.
08/03/17
FBCO
08/03/17
NO CHANGE
Target $80
FBCO
Outperform
Spirit AeroSystems price target raised to $80 from $74 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Spirit AeroSystems (SPR) to $80 from $74 following the "surprise announcement" that the company had reached a key master pricing agreement with Boeing (BA). The analyst expects shares to be up strongly, followed by profit takers who, once the euphoria wears off, would resume worrying about aerostructures supplier disintermediation and the possible price reductions Spirit AeroSystems may have agreed to down the road. Spingarn reiterates an Outperform rating on Spirit AeroSystems' shares.
08/03/17
GHSC
08/03/17
UPGRADE
Target $83
GHSC
Buy
Spirit AeroSystems upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Josh Sullivan upgraded Spirit AeroSystems to Buy with and raised its price target to $83 from $62 following the establishment of an MOU with Boeing for the 737-MAX/787-9/787-10 long-term agreements. Spirit offers direct linkage to the aerospace cycle and the newly signed MOU is fair and equitable to both parties, the analyst wrote.
06/05/17
SBSH
06/05/17
NO CHANGE
Target $70
SBSH
Buy
Citi sees path for Spirit AeroSystems hitting $85/share
Spirit AeroSystems (SPR) is trading near its all-time deepest earnings discount versus Boeing (BA) despite Spirit generating better financial results, Citi analyst Jason Gursky tells investors in a research note. While the protracted Boeing negotiation is an overhang, it is already reflected in the multiple, the analyst argues. He highlights Spirit's improving cash flow, balance sheet flexibility, shareholder-friendly cash deployment and new growth opportunities. He sees a path to $85 per share "over time" and reiterates a Buy rating on the shares with a one-year target of $70.
ERJ Embraer
$20.65

-0.75 (-3.50%)

06/21/17
COWN
06/21/17
DOWNGRADE
Target $24
COWN
Market Perform
Embraer downgraded to Market Perform from Outperform at Cowen
Cowen analyst Cai Von Rumohr downgraded Embraer to Market Perform from Outperform to reflect the increasing likelihood of a transitional earnings dip as E2 enters production with another year of cash outflow in 2018. Although 2019 looks notionally better, the stock faces a tough earnings revision set-up in the second half of this year. Von Rumohr lowered his price target to $24 from $27 on Embraer shares.
12/01/16
12/01/16
UPGRADE

Embraer upgraded to Buy from Neutral at BTG Pactual
08/10/17
08/10/17
DOWNGRADE
Target $18

Sell
Embraer downgraded to Sell from Buy at Goldman Sachs
As previously reported, Goldman Sachs analyst Noah Poponak downgraded Embraer to Sell from Buy and lowered his price target on the stock to $18 from $26 saying he expects new margin headwinds going forward. Poponak said challenges remain in business jet and Brazil Defense and believes EBIT and cash flow could disappoint given weak volumes and pricing ahead. He also notes a cost reduction plan has already been implemented.
06/21/17
06/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Neutral from Buy at BofA/Merrill with analyst Vivek Arya saying he fears increased competition from AMD (AMD) in servers and Nvidia (NVDA) share gains in AI and accelerators could limit Intel's average selling price expansion, which he notes has been a key source of its growth. Arya cut his price target on Intel shares to $38 from $42. 2. Target (TGT) downgraded to Neutral from Buy at Citi. 3. Chevron (CVX) downgraded to Neutral from Outperform at Macquarie. 4. Schlumberger (SLB) downgraded to Equal Weight from Overweight at Barclays with analyst J. David Anderson saying that based on strip prices and the firm's oil price forecast he expects 2018 North America E&P spending to be up about 10-15%. 5. Embraer (ERJ) downgraded to Market Perform from Outperform at Cowen with analyst Cai Von Rumohrciting the increasing likelihood of a transitional earnings dip as E2 enters production with another year of cash outflow in 2018. Although 2019 looks notionally better, the stock faces a tough earnings revision set-up in the second half of this year. Von Rumohr lowered his price target to $24 from $27 on Embraer shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ESL Esterline
$85.85

-1.75 (-2.00%)

01/12/17
JEFF
01/12/17
DOWNGRADE
Target $92
JEFF
Hold
Esterline downgraded to Hold from Buy at Jefferies
Jefferies analyst Howard Rubel downgraded Esterline Technologies to Hold saying he's become more selective for the Aerospace & Defense Electronics space with valuations and expectations higher post the U.S. election. The analyst keeps a $92 price target for the shares.
08/10/17
GSCO
08/10/17
DOWNGRADE
Target $75
GSCO
Sell
Esterline downgraded to Sell from Neutral at Goldman Sachs
Goldman analyst Noah Poponak downgraded Esterline to Sell and cut its price target to $75 from $86 citing margin challenges and growth headwinds in Aero and the non-A&D businesses. Further, the analyst said there are signs the company is losing share or price, and believes initial 2018 guidance could be below expectations.
08/04/17
FBCO
08/04/17
DOWNGRADE
Target $100
FBCO
Neutral
Esterline downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Robert Spingarn downgraded Esterline to Neutral and cut its price target to $100 from $106 saying shares are fully priced based FY18 estimates that were trimmed due to a higher tax rate and moderation in his sales and margin forecast.
01/19/17
RHCO
01/19/17
INITIATION
RHCO
Buy
Esterline initiated with a Buy at SunTrust
SunTrust analyst Michael Ciarmoli started coverage of Esterline with a $106 price target and a Buy rating.
RTN Raytheon
$180.50

1.2 (0.67%)

08/08/17
08/08/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), Alphabet (GOOG, GOOGL), and Facebook (FB) were reinstated with a Buy at Mizuho, while eBay (EBAY) and Twitter (TWTR) were reinstated with an Underperform. 2. Broadridge (BR) initiated with a Neutral at DA Davidson. 3. Brighthouse Financial (BHF) initiated with an Overweight at Barclays. 4. Akcea Therapeutics (AKCA) WAS initiated with an Outperform at BMO Capital and Cowen, an Outperform at Wells Fargo, as well as a Buy at Stifel. 5. Lockheed Martin (LMT) and Raytheon (RTN) were initiated with an Overweight at Morgan Stanley, while Northrop Grumman (NOC) was initiated with an Equal Weight, and General Dynamics (GD) was initiated with an Underweight at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
BARD
08/10/17
NO CHANGE
Target $212
BARD
Outperform
Raytheon price target raised to $212 from $170 at Baird
Baird analyst Peter Arment raised his price target on Raytheon to $212 from $170 to reflect significant program wins both domestically and internationally for missile defense and missile systems that puts the company in position for favorable organic growth in 2018 and beyond. Arment reiterated his Outperform rating on Raytheon shares.
08/08/17
MSCO
08/08/17
INITIATION
Target $188
MSCO
Overweight
Raytheon initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated Raytheon with an Overweight and a $188 price target saying it has leading positions in high demand areas of missile defense and internationally, and optionality around an A-rated balance sheet.
08/04/17
ARGS
08/04/17
NO CHANGE
ARGS
Raytheon price target raised to $195 from $175 at Argus
Argus analyst John Eade raised his price target on Raytheon after the company reported stronger than expected Q2 results and raised its 2017 guidance. The analyst keeps a Buy rating on the shares.
LMT Lockheed Martin
$306.81

1.59 (0.52%)

07/19/17
FBCO
07/19/17
NO CHANGE
Target $300
FBCO
Neutral
Lockheed Martin price target raised to $300 from $280 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $300 from $280 as he expects shares to grind higher with continued earnings growth, perhaps tempered a little by flattish CF largely due to contract timing. He reiterates a Neutral rating on the shares.
07/19/17
ARGS
07/19/17
NO CHANGE
ARGS
Lockheed Martin price target raised to $320 from $290 at Argus
Argus analyst John Eade increased his price target on Lockheed Martin after the company reported higher than expected Q2 EPS. The analyst notes that U.S. defense spending is rising, while geopolitical tensions are increasing. Calling the stock's valuation attractive, he keeps a Buy rating on the shares.
08/08/17
MSCO
08/08/17
INITIATION
Target $342
MSCO
Overweight
Lockheed Martin initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated Lockheed Martin with an Overweight and a $342 price target saying it has the right balance of segment margin growth, revenue visibility, and leading 5-year CAGR, all supported by the F-35 ramp over the coming years, combined with pension benefits.
NOC Northrop Grumman
$273.05

-0.05 (-0.02%)

08/08/17
MSCO
08/08/17
INITIATION
Target $279
MSCO
Equal Weight
Northrop Grumman initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated Northrop Grumman with an Equal Weight and a $279 price target saying its leading revenue profile is offset by light free cash flow yields and margin growth.
05/10/17
VERT
05/10/17
UPGRADE
VERT
Buy
Northrop Grumman upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Robert Stallard upgraded Northrop Grumman to Buy from Hold with a $270 price target telling investors defense sector fundamentals remain positive and share underperformance versus peers provides a buying opportunity.
04/18/17
RBCM
04/18/17
NO CHANGE
RBCM
Defense stocks should be bought on any weakness, says RBC Capital
RBC Capital analyst Matthew McConnell,recommends buying defense stocks on any weakness caused by near-term funding uncertainties. The analyst says that the impact of a government shutdown on the sector would be "minor and short-lived," while geopolitical tensions have increased. Publicly traded companies in the space include BAE Systems (BAESY), Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC), Raytheon (RTN) and United Technologies (UTX).
LLL L3 Technologies
$183.65

1.92 (1.06%)

08/08/17
08/08/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Argus with analyst William Selesky saying he expects Tesla to reach breakeven two quarters earlier than he'd previously forecast and sees the company achieving full-year profitability in fiscal 2019. 2. L3 Technologies (LLL) upgraded to Buy from Hold at Drexel Hamilton analyst Pete Skibitski saying he is "cautiously" optimistic that there will be a positive resolution in fiscal 2018 budget negotiations, which will benefit the entire space, and notes L3's international outlook has improved as the year has progressed. 3. Foot Locker (FL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jay Sole saying he believes share weakness related to investor concerns surrounding share loss to Amazon (AMZN) and brands' own websites has created an "excellent" buying opportunity. 4. UPS (UPS) upgraded to Buy from Neutral at Citi with analyst Christian Wetherbee saying he sees a "clear path" toward double-digit earnings growth returning in 2018. 5. Cognizant (CTSH) upgraded to Buy from Hold at Berenberg with analyst Georgios Kertsos saying the market now considers U.S. immigration policy changes as unlikely, which leaves upside for investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
08/08/17
UPGRADE
Target $204

Buy
L3 Technologies upgraded to Buy at Drexel Hamilton
As previously reported, Drexel Hamilton upgraded L3 Technologies and established a $204 price target. Analyst Pete Skibitski is "cautiously" optimistic that there will be a positive resolution in FY18 budget negotiations, which will benefit the entire space, and notes L3's international outlook has improved as the year has progressed.
08/08/17
DRXL
08/08/17
UPGRADE
DRXL
Buy
L3 Technologies upgraded to Buy from Hold at Drexel Hamilton
08/07/17
08/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Deere (DE) upgraded to Conviction Buy from Buy at Goldman Sachs. 2. Chemours (CC) upgraded to Neutral from Sell at UBS with analyst John Roberts saying Chemours' execution has disproved his prior concerns. 3. BP (BP) upgraded to Overweight from Neutral at Piper Jaffray with analyst Guy Baber saying the company's cash flow generation is in the early stages of a "multi-year positive inflection" while Macondo headwinds are subsiding. 4. L3 Technologies (LLL) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Nosh Poponak saying he favors increased exposure to Defense given the current industry cycle position, geopolitics, and Department of Defense budget dynamics. 5. Illumina (ILMN) upgraded to Buy from Hold at Canaccord with analyst Mark Massaro saying he sees a strong upgrade cycle for NovaSeq beginning in the tird quarter and lasting for three years. He believes we remain in the early innings on major waves of cancer growth and expects the continuation of robust growth of direct to consumer products, such as 23andMe, ancestry.com and now Helix. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:23
08/18/17
08/18
14:23
08/18/17
14:23
Earnings
Breaking Earnings news story on MiMedx »

MiMedx backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

RPM

RPM

$48.24

-0.58 (-1.19%)

14:21
08/18/17
08/18
14:21
08/18/17
14:21
Upgrade
RPM rating change  »

RPM upgraded to Gradually…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:21
08/18/17
08/18
14:21
08/18/17
14:21
Hot Stocks
MiMedx in pact to divest Stability Biologics, focus on biopharma »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

$NSD

NASDAQ Market Internals

14:17
08/18/17
08/18
14:17
08/18/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
08/18/17
08/18
14:16
08/18/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRBT

iRobot

$98.82

-3.55 (-3.47%)

14:12
08/18/17
08/18
14:12
08/18/17
14:12
Periodicals
Spruce Point questions iRobot's financial guidance »

Spruce Point Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:11
08/18/17
08/18
14:11
08/18/17
14:11
Hot Stocks
Breaking Hot Stocks news story on MiMedx »

MiMedx in pact to divest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$24.62

-0.1264 (-0.51%)

14:00
08/18/17
08/18
14:00
08/18/17
14:00
Options
19K GE Oct 27 - Jan 27 call spreads at 20c on ISE »

19K GE Oct 27 - Jan 27…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 02

    Oct

RTNB

root9B Technologies

$0.60

-0.1665 (-21.72%)

14:00
08/18/17
08/18
14:00
08/18/17
14:00
Hot Stocks
Breaking Hot Stocks news story on root9B Technologies »

root9B Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MATX

Matson

$22.53

-6.8159 (-23.22%)

13:56
08/18/17
08/18
13:56
08/18/17
13:56
Hot Stocks
Matson drops after competitor TOTE enters Hawaii trade route »

Matson (MATX), which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.52

0.4256 (0.18%)

, SPX

S&P 500

13:51
08/18/17
08/18
13:51
08/18/17
13:51
Periodicals
Breitbart's Pollak tweets '#WAR', after Steve Bannon departs White House »

Senior-editor-at-large…

SPY

SPDR S&P 500 ETF Trust

$243.52

0.4256 (0.18%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$17.68

-0.115 (-0.65%)

13:50
08/18/17
08/18
13:50
08/18/17
13:50
Options
Short-term call buyers in KeyCorp »

Short-term call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

FB

Facebook

$166.91

-3.09 (-1.82%)

13:46
08/18/17
08/18
13:46
08/18/17
13:46
Hot Stocks
Facebook's Zuckerberg says plans to take two months of paternity leave »

Facebook's Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

  • 13

    Sep

AMC

AMC Entertainment

$12.53

-0.625 (-4.75%)

13:45
08/18/17
08/18
13:45
08/18/17
13:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 14

    Sep

  • 27

    Sep

TEVA

Teva

$17.21

0.11 (0.64%)

13:40
08/18/17
08/18
13:40
08/18/17
13:40
Hot Stocks
Teva announces exclusive launch of generic Axiron in the U.S. »

Teva announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

LGF.A

Lionsgate

$28.25

0.21 (0.75%)

, LGF.B

Lionsgate

$27.18

0.175 (0.65%)

13:37
08/18/17
08/18
13:37
08/18/17
13:37
Hot Stocks
Box Office Battle: 'Annabelle: Creation' to remain in first place »

The major film release…

LGF.A

Lionsgate

$28.25

0.21 (0.75%)

LGF.B

Lionsgate

$27.18

0.175 (0.65%)

TWX

Time Warner

$101.58

-0.03 (-0.03%)

DIS

Disney

$101.02

-0.36 (-0.36%)

VIA

Viacom

$42.40

1.75 (4.31%)

VIAB

Viacom

$29.21

-0.61 (-2.05%)

FOX

21st Century Fox

$26.89

-0.67 (-2.43%)

FOXA

21st Century Fox

$27.35

-0.64 (-2.29%)

SNE

Sony

$38.85

-0.15 (-0.38%)

CMCSA

Comcast

$40.27

-0.97 (-2.35%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 27

    Sep

  • 29

    Sep

MATX

Matson

$22.40

-6.9536 (-23.69%)

13:29
08/18/17
08/18
13:29
08/18/17
13:29
Upgrade
Matson rating change  »

Matson upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$39.06

0.02 (0.05%)

, FB

Facebook

$166.91

-3.09 (-1.82%)

13:28
08/18/17
08/18
13:28
08/18/17
13:28
Hot Stocks
Live Nation drops sharply after Facebook adding ticket sales »

Shares of Live Nation…

LYV

Live Nation

$39.06

0.02 (0.05%)

FB

Facebook

$166.91

-3.09 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Aug

  • 24

    Aug

  • 13

    Sep

BZUN

Baozun

$33.50

-1.98 (-5.58%)

13:25
08/18/17
08/18
13:25
08/18/17
13:25
Options
Baozun call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

FB

Facebook

$166.91

-3.09 (-1.82%)

, EBAY

eBay

$34.85

-0.51 (-1.44%)

13:20
08/18/17
08/18
13:20
08/18/17
13:20
Periodicals
Facebook adding ticket sales to Marketplace, Recode reports »

Facebook's (FB)…

FB

Facebook

$166.91

-3.09 (-1.82%)

EBAY

eBay

$34.85

-0.51 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

  • 28

    Aug

  • 29

    Aug

  • 07

    Sep

  • 13

    Sep

PEI

Pennsylvania REIT

$10.11

-0.28 (-2.69%)

, FL

Foot Locker

$34.98

-12.72 (-26.67%)

13:18
08/18/17
08/18
13:18
08/18/17
13:18
Periodicals
Pennsylvania REIT falls after Foot Locker weakness, Bloomberg says »

Shares of Pennsylvania…

PEI

Pennsylvania REIT

$10.11

-0.28 (-2.69%)

FL

Foot Locker

$34.98

-12.72 (-26.67%)

LB

L Brands

$36.28

-1.27 (-3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

SPX

S&P 500

13:17
08/18/17
08/18
13:17
08/18/17
13:17
Hot Stocks
WH Press Sec.: Kelly, Bannon 'mutually agreed today would be Steve's last day' »

A statement from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
08/18/17
08/18
13:17
08/18/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
08/18/17
08/18
13:16
08/18/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

13:15
08/18/17
08/18
13:15
08/18/17
13:15
Periodicals
Kelly, Bannon 'mutually agreed today would be Steve's last day,' CNBC tweets »

Citing the White House…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.